Chinese pharma’s history of counterfeits, fakes, and quality issues
In the last 20 years, Beijing has turned healthcare into a national priority. But the country's history of counterfeit drugs and weak regulation casts a lingering shadow. The topic is particularly pertinent now, with Beijing's COVID-19 vaccine diplomacy in full swing.
